Fiona H. Marshall
President, Biomedical Research at Novartis
Merck•Cambridge, Massachusetts, United States
View LinkedIn ProfileExperience37+ Years
Executive Overview
I'm inspired by learning new things that change our outlook on life. That's why I am so excited to lead early-stage research at Novartis, working with discovery teams renowned for their collaborative science and use of cutting-edge technologies. Every day, I collaborate with colleagues across Novartis and partners across the biopharma ecosystem to accelerate the translation of scientific discoveries into breakthrough, high-value medicines that address critical areas of unmet need for patients.
Career Timeline
- NovartisCurrentNov 2022–Present· 3 yrs 11 mos
- President, Biomedical ResearchCurrentNov 2022–Present
- MerckCurrent2019–Present· 7 yrs 9 mos
- Senior Vice President, Head of Discovery, Preclinical and Translational MedicineCurrentApr 2021–Dec 2025
- Senior Vice President Head of Discovery Sciences and Translational Medicine2021–Apr 2021
- VP Head of Neuroscience2019–2021
- Apr 2018–Sep 2019· 1 yr 5 mos
- VP Head of Discovery Research MRL UKApr 2018–Sep 2019
- Jul 2006–Mar 2018· 11 yrs 8 mos
- Executive Vice President and Chief Scientific OfficerJun 2015–Mar 2018
- Chief Scientific Officer and Founder of Heptares TherapeuticsJul 2006–Mar 2018
- 2002–2006· 4 yrs
- Independent Consultant to Venture Capital and Biotech companies2002–2006
- 2002–2006· 4 yrs
- Visiting Lecturer2002–2006
- 2000–2002· 2 yrs
- Director Biology Europe2000–2002
- 1995–2000· 5 yrs
- Head of Molecular Pharmacology1998–2000
- Head of Receptor Systems Unit1995–1998
- 1989–1994· 5 yrs
- Group Leader Neuropharmacology1989–1994
Education
PhD
Neuroscience
University of CambridgeBSc Hons
Biochemistry
University of BathExecutive Relationship Map
Reports To
Fiona H. Marshall
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
GPCRsProtein ChemistryPharmacologyDrug DesignIon ChannelsDrug DiscoveryMolecular PharmacologyOncologyNeuropharmacologyBiomarker DiscoveryKinasesDiabetesHigh Throughput ScreeningStrategyGenomicsPharmaceuticsClinical TrialsCancer ResearchLifesciencesBiotechnology